Neuromodulation

Type: Keyphrase
Name: Neuromodulation
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

"Methods of Administering Drugs in an Implantable Multi-Chamber Pump" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Gibson, Susan P. (Menlo Park, CA); Vanhove, Geertrui F. (Menlo Park, CA), filed on March 27, 2014, was made available online on October 9, 2014, according to news ... [Published Pharmacy Choice - Oct 16 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

St. Jude Medical Q3 leaders and laggards

News EditorSt. Jude Medical (NYSE:STJ) Q3 revenue growth by selected line item:Leaders: Intl Neuromodulation: +14.3%; International Atrial Fibrillation: +11.5%; WW Atrial Fibrillation: +7.7%; U.S. Cardiovascular: +5.3%.Laggards: International ICD: -3.0%; ... [Published Seeking Alpha - Oct 15 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

St. Jude To Report Q3 Earnings This Week

St. Jude Medical is expected to report 3Q earnings on October 15. Analysts' estimates are in line with the company's earnings guidancePage 1 of 2Click Ticker to See live coverageSt. Jude Medical, Inc. ( STJ ) is expected to report earnings for the third ... [Published Bidness Etc - Oct 13 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 4 reports

Helius Medical Technologies Inventors Granted US Patent No. 8,849,407, Non-Invasive Neuromodulation (NINM) for Rehabilitation of Brain Function

NEWTOWN, PA / Helius’ patent strategy, which is being executed by Joe Capraro and his team at Proskauer Rose LLP, is to pursue patent protection for the core platform technology as well to patent protect evolving device design concepts. Helius has numerous ... [Published KXXV-TV - Oct 07 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 3 reports

Research and Markets: Emerging Trends in Neuromodulators - Opportunity Evaluation And Roadmapping

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/np8k5r/emerging_trends) has announced the addition of the "Emerging Trends in Neuromodulators (Technical Insights)" report to their offering. This research service ... [Published Business Wire Technology News - Oct 06 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Emerging Trends in Neuromodulators

Exciting Technological and Business Vistas on the HorizonThis research service showcases existing, emerging and cutting-edge Neuromodulation technologies. The report studies the role of Neuromodulation in pain management, treatment of neurological, psychiatric, ... [Published Global Information Inc - Oct 03 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

MJ Freeway to Host Educational Webinars Regarding Crucial Marijuana Legalization Efforts in Alaska, Nevada and Oregon

(Date:10/1/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... agreement with Patterson Veterinary Supply. Patterson ... of Abaxis veterinary ... [Published Bio-Medicine - Oct 02 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

Feasibility Study of GTEN 100 Neuromodulation

Electrical Geodesics, Inc. in EpilepsyEUGENE, OREGON, US, 2 October 2014The initial study will assess the feasibility of use of the GTEN 100 in temporary seizure suppression in patients with drug-resistant epilepsy using both pulsed and sustained protocols. ... [Published MoneyAM - Oct 02 2014]
First reported Sep 30 2014 - Updated Oct 01 2014 - 7 reports

Helius Medical announces receipt of prototype Portable Neuromodulation Stimulator device from Ximedica

Helius Medical Technologies announced that it has completed the Commercial Design Specification phase of its commercial version of the Portable Neuromodulation Stimulator device (the PoNS) and received the first prototypes from Ximedica.To date, all clinical ... [Published Medical Devices Business Review - Oct 01 2014]
First reported Sep 27 2014 - Updated Sep 27 2014 - 1 reports

Neuromodulation Market to be Worth $6.8 Billion Globally by 2017

Global neuromodulation market to be worth $6.8 billion by 2017. RNR presents analysis and discussion about neuromodulation market, its forecasts and more is now available in the global research report “Neuromodulation Market – [Spinal Cord Stimulation ... [Published MyNewsDesk - Sep 27 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Medtronic Acquires Sapiens Steering Brain Stimulation

Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering ... [Published PR inside - Sep 23 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Administrative Coordinator -Medical Association | Association Management Center

The North American Neuromodulation Society (NANS) seeks a Coordinator to provide program support for this growing medical subspecialty society and its foundation. NANS is dedicated to being the premier organization representing neuromodulation. NANS promotes ... [Published Associations Now Magazine - Sep 22 2014]

Quotes

The following quote was obtained by the news editors from the background information supplied by the inventors: "Omega conopeptides have been provided for analgesia alone and in combination with other analgesics. This administration can be by an implantable pump. It has been found that the admixture of omega conopeptides with other compounds can lower the stability of omega conopeptides and can cause corrosion in some pumps."

More Content

All (89) | News (67) | Reports (0) | Blogs (17) | Audio/Video (0) | Fact Sheets (4) | Press Releases (1)
sort by: Date | Relevance
"Methods of Administering Drugs in an Implantab... [Published Pharmacy Choice - Oct 16 2014]
St. Jude Medical Q3 leaders and laggards [Published Seeking Alpha - Oct 15 2014]
St. Jude Medical Reports Third Quarter 2014 Res... [Published Scottrade - Oct 15 2014]
Healthcare Industry Leader Kenneth H. Paulus Jo... [Published TickerTech.com - Oct 15 2014]
The Canadian Pain Coalition States Urgency to I... [Published BusinessWeek - Oct 14 2014]
Vital Health, Inc. Now Offers Blood Chemistry W... [Published PRWeb - Oct 13 2014]
St. Jude To Report Q3 Earnings This Week [Published Bidness Etc - Oct 13 2014]
Will St. Jude Medical (STJ) Disappoint this Ear... [Published Zacks.com - Oct 13 2014]
Uroplasty to Announce Second Quarter Fiscal Yea... [Published Noodls - Oct 09 2014]
Uroplasty to Announce Second Quarter Fiscal Yea... [Published 4 Traders - Oct 09 2014]
Helius Medical Technologies Inventors Granted U... [Published KXXV-TV - Oct 07 2014]
Helius Medical Technologies’ Inventors Granted ... [Published Digital Journal - Oct 07 2014]
Helius Medical Technologies’ Inventors Granted ... [Published Business Wire Health News - Oct 07 2014]
Helius Medical's PoNS receives U.S. patent [Published Stockwatch - Oct 07 2014]
Research and Markets: Emerging Trends in Neurom... [Published Business Wire Technology News - Oct 06 2014]
Research and Markets: Emerging Trends in Neurom... [Published Business Wire Health News - Oct 06 2014]
Emerging Trends in Neuromodulators - Opportunit... [Published Individual.com - Oct 06 2014]
Spinal Cord Stimulator in Chronic Neuropathic B... [Published General Medicine eJournal - Oct 06 2014]
Emerging Trends in Neuromodulators [Published Global Information Inc - Oct 03 2014]
MJ Freeway to Host Educational Webinars Regardi... [Published Bio-Medicine - Oct 02 2014]
Tapentadol: A welcome addition in the battle ag... [Published Irish Medical Times - Oct 02 2014]
Feasibility Study of GTEN 100 Neuromodulation [Published MoneyAM - Oct 02 2014]
Flowonix Submits PMA Supplements for Prometra I... [Published Fierce Drug Delivery - Oct 01 2014]
Helius Medical announces receipt of prototype P... [Published Medical Devices Business Review - Oct 01 2014]
Helius Medical Technologies Announces the Recei... [Published Fort Mills Times - Sep 30 2014]
Helius Medical Technologies Announces the Recei... [Published Digital Journal - Sep 30 2014]
Helius Medical Technologies Announces the Recei... [Published EON Science - Sep 30 2014]
Helius Medical Technologies Announces the Recei... [Published Business Wire Science: Science News - Sep 30 2014]
Helius Medical Technologies Announces the Recei... [Published Business Wire Health News - Sep 30 2014]
Helius receives Pons prototype from Ximedica [Published Stockwatch - Sep 30 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Helius Medical Technologies’ Inventors Granted ... [Published Business Wire Health News - Oct 07 2014]
NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies is granted U.S. Patent No. 8,849,407, “Non-Invasive Neuromodulation (NINM) for Rehabilitation of Brain Function ...
Research and Markets: Emerging Trends in Neurom... [Published Business Wire Technology News - Oct 06 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/np8k5r/emerging_trends) has announced the addition of the "Emerging Trends in Neuromodulators (Technical Insights)" report to their offering. This research service ...
Research and Markets: Emerging Trends in Neurom... [Published Business Wire Health News - Oct 06 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/np8k5r/emerging_trends) has announced the addition of the "Emerging Trends in Neuromodulators (Technical Insights)" report to their offering. This research service ...
Helius Medical Technologies Announces the Recei... [Published EON Science - Sep 30 2014]
NEWTOWN, Pa.--(EON: Enhanced Online News)--Helius Medical Technologies, Inc. (CSE:HSM) is pleased to announce that it has completed the Commercial Design Specification phase of its commercial version of the Portable Neuromodulation Stimulator ...
Helius Medical Technologies Announces the Recei... [Published Business Wire Science: Science News - Sep 30 2014]
NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies, Inc. (CSE:HSM) is pleased to announce that it has completed the Commercial Design Specification phase of its commercial version of the Portable Neuromodulation Stimulator ...
1 2 3 4

Press Releases

sort by: Date | Relevance
U.S. Neuromodulation Market Trends and Outlook ... [Published GlobeNewswire: Advertising News - Aug 05 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.